GNCC Capital, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
28/100
20
Profitability
20
Growth
40
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNCP research report →
52-Week Range49% of range
Low $0.00
Current $0.00
High $0.00
Companywww.gncc-capital.com
GNCC Capital, Inc. through its subsidiary, BioCann Pharma S. A.
- CEO
- Nicolaas Edward Blom
- IPO
- 2009
- Employees
- 900
- HQ
- Las Vegas, NV, US
Price Chart
-50.00% · this period
Valuation
- Market Cap
- $8.71M
- P/E
- -6.29
- P/S
- 0.00
- P/B
- -4.76
- EV/EBITDA
- -25.89
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 357.90%
- ROIC
- -15.50%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-555,454 · 6.68%
- EPS
- $0.00 · 0.00%
- Op Income
- $-555,450
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -28.33
- Avg Volume
- 2.97M
Get TickerSpark's AI analysis on GNCP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GNCP Coverage
We haven't published any research on GNCP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNCP Report →